Unearthing roles for the gut microbiome

Nature Reviews Urology

Volumn 15, Issue 10, 2018, Pages 589-

  Fenner, Annette ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENZALUTAMIDE; PROGRAMMED DEATH 1 LIGAND 1; ANDROGEN;

AKKERMANSIA MUCINIPHILA; AMPLICON; BACTEROIDES; BIFIDOBACTERIALES; BREVIBACTERIACEAE; CANCER IMMUNOTHERAPY; CARBOHYDRATE METABOLISM; ERYSIPELOTRICHACEAE; FECES ANALYSIS; HUMAN; INTESTINE FLORA; LACHNOSPIRACEAE; MICROBIAL DIVERSITY; NONHUMAN; NOTE; PRIORITY JOURNAL; PROSTATE CANCER; RNA SEQUENCE; RUMINOCOCCACEAE; SPECIES RICHNESS; STREPTOCOCCACEAE; STREPTOCOCCUS; HORMONE SUBSTITUTION; MALE; PROSTATE TUMOR;

ANDROGENS; GASTROINTESTINAL MICROBIOME; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 85052602374     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/s41585-018-0068-z     Document Type: Note

References (2)

1. Liss, M. A. et al. Metabolic biosynthesis pathways identified from fecal microbiome associated with prostate cancer. Eur. Urol. 10.1016/j.eururo.2018.06.033 (2018)
2. Sfanos, K. S. et al. Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies. Prostate Cancer Prostatic Dis. 10.1038/s41391-018-0061-x (2018)